Current AffairsIndustry News

Breakthrough drug could delay a leading cause of death in dogs

A breakthrough drug may be the answer to managing the most common form of canine heart disease, potentially extending the lives of dogs worldwide.

The global EPIC study, led by Professor Adrian Boswood of the Royal Veterinary College, has found that treatment with the drug pimobendan delays the onset of heart failure secondary to mitral valve disease (MVD), the most common form of heart disease in dogs.

Back to top button